Genetic testing subsidies for hereditary breast, ovarian cancer to start on Dec 1

AI Summary

Singapore will begin subsidizing genetic tests for hereditary breast and ovarian cancer on December 1. Doctors say the assistance could help families identify inherited risks earlier and consider preventive measures, with about 2,000 people expected to benefit annually.

About 2,000 people are expected to benefit each year, with doctors saying the subsidies could help more families identify hereditary risks early and take preventive action.